SAN FRANCISCO, TORONTO and ZÜRICH, Switzerland, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a clinical-stage biotech company focused on the development of endogenous regenerative ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The investigational cell therapy is designed to replace ...
MUNICH, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- ViGeneron GmbH, a next-generation clinical-stage gene therapy company, today announced that the first patient has been dosed in its Phase Ib ...
– DSP-3077, an investigational allogeneic iPS cell-derived retinal sheet (3-dimensional [3D] retina), is being evaluated in patients in a Phase 1/2 study – – Retinitis pigmentosa (RP) is a group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results